Target Low-Density Lipoprotein-Cholesterol and Secondary Prevention for Patients with Acute Myocardial Infarction: A Korean Nationwide Cohort Study

Achievement of LDL-C Targets Defined by ESC/EAS (2011) Guidelines in Risk-Stratified Korean Patients with Dyslipidemia Receiving Lipid-Modifying Treatments

(2020) Ye Seul Yang et al.   Endocrinology and Metabolism

Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study

(2020) Jessica Schubert et al.   EUROPEAN HEART JOURNAL

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol

(2019) Scott M. Grundy et al.   CIRCULATION

2018 Guidelines for the management of dyslipidemia

(2019) Eun-Jung Rhee et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   EUROPEAN HEART JOURNAL

Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995–2014

(2017) Karolina Szummer et al.   EUROPEAN HEART JOURNAL

Clinical Outcomes according to the Achievement of Target Low Density Lipoprotein-Cholesterol in Patients with Acute Myocardial Infarction

(2017) Taehoon Ahn et al.   Korean Circulation Journal

Introduction to the Analysis of Survival Data in the Presence of Competing Risks

(2016) Peter C. Austin et al.   CIRCULATION

Multicenter Cohort Study of Acute Myocardial Infarction in Korea　– Interim Analysis of the Korea Acute Myocardial Infarction Registry-National Institutes of Health Registry –

(2016) Ju Han Kim et al.   CIRCULATION JOURNAL

Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions

(2016) Michael G. Silverman et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Comparison of the effects of two low-density lipoprotein cholesterol goals for secondary prevention after acute myocardial infarction in real-world practice: ≥50% reduction from baseline versus

(2015) Kyung Hoon Cho et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials

(2015)   LANCET

Consideration of a New Definition of Clinically Relevant Myocardial Infarction After Coronary Revascularization

(2013) Issam D. Moussa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

(2013)   LANCET

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

(2010)   LANCET